ELI LILLY & Co — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-02-16

Reporting Person: Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-16	Common Stock	M	5461	—	Acquired	10153	Direct
2022-02-16	Common Stock	F	2186	$243.84	Disposed	7967	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-16	Restricted Stock Unit	$	M	5461	Disposed	2022-02-16	Common Stock (5461.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4342	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.